25.04.19: Q1 2019 Investor Conference Call
Q1 2019 Investor Conference CallLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 11, 2019 Category: Pharmaceuticals Source Type: news
04.04.19: Bankhaus Lampe German Conference, Baden-Baden, Germany
Bankhaus Lampe German Conference, Baden-Baden, GermanyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 1, 2019 Category: Pharmaceuticals Source Type: news
08.05.19: Deutsche Bank Healthcare Conference, Boston, U.S.A.
Deutsche Bank Healthcare Conference, Boston, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 1, 2019 Category: Pharmaceuticals Source Type: news
16.05.19: BMO Annual Farm to Market Conference, New York, U.S.A.
BMO Annual Farm to Market Conference, New York, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 1, 2019 Category: Pharmaceuticals Source Type: news
21.05.19: Bernstein Agriculture Conference, London, UK
Bernstein Agriculture Conference, London, UKLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 1, 2019 Category: Pharmaceuticals Source Type: news
22.05.19: Berenberg US Conference, Tarrytown, U.S.A.
Berenberg US Conference, Tarrytown, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 1, 2019 Category: Pharmaceuticals Source Type: news
29.05.19: UBS Best of Europe 1o1 Conference, New York, U.S.A.
UBS Best of Europe 1o1 Conference, New York, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 1, 2019 Category: Pharmaceuticals Source Type: news
27.03.19: Bayer statement on jury's decision in phase two of California glyphosate trial
Bayer statement on jury's decision in phase two of California glyphosate trialmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 28, 2019 Category: Pharmaceuticals Source Type: news
25.03.19: Bayer reaches settlement to resolve Xarelto™ litigation
Bayer reaches settlement to resolve Xarelto™ litigationmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 25, 2019 Category: Pharmaceuticals Source Type: news
19.03.19: Bayer statement on jury's decision in phase one of California glyphosate trial
Bayer statement on jury's decision in phase one of California glyphosate trialmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 20, 2019 Category: Pharmaceuticals Source Type: news
08.03.19: Not intended for U.S. and UK Media
Bayer submits European marketing authorization application for darolutamideThird submission for darolutamide in two weeks underscores Bayer's commitment to fill an unmet need for men with nmCRPC worldwide / Regulatory submission based on positive data from Phase III study ARAMISmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 8, 2019 Category: Pharmaceuticals Source Type: news
06.03.19: Roadshow New York, USA
Roadshow New York, USALink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 5, 2019 Category: Pharmaceuticals Source Type: news
05.03.19: Not intended for U.S. and UK Media
Bayer submits darolutamide for marketing authorization in JapanRegulatory submission based on positive data from Phase III ARAMIS studymehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 5, 2019 Category: Pharmaceuticals Source Type: news
27.02.20: Annual Report 2019
Annual Report 2019All investor conferences (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 27, 2019 Category: Pharmaceuticals Source Type: news
27.04.20: Q1 2020 Quarterly Statement
Q1 2020 Quarterly StatementLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 27, 2019 Category: Pharmaceuticals Source Type: news
